Dr. Chelsea Boet joined PALTOWN’s board in 2018. She brings her experience as a stage iv patient and COLONTOWN member to our work. Read this profile, published in Spectrum Health’s Health Beat.… Read more ““No day is a given” – board member Chelsea Boet talks about being a mom, a doctor, and a patient”
A New Patient Voice for Clinical Trials
PALTOWN CEO Erika Brown has been elected to the National Cancer Institute’s Colon and Rectal Cancer Task Force. The Task Force develops recommendations for priorities for publicly-funded clinical research, as part of the National Cancer Institute’s Gastrointestinal Steering Committee. The work of the Task Force and the Steering Committee provides critical input to the National Cancer Institute, the largest funder of cancer research in the world.
Erika and I recently attended the 2017 American Society of Clinical Oncology (ASCO) meeting in Chicago, aided in part by a patient advocate scholarship offered by ASCO and its Conquer Cancer Foundation.
ASCO is the largest gathering of cancer researchers and clinicians in the world, and it attracts a considerable number of advocates, patients, drug and device companies — anyone and everyone in “cancer land.” There are always a huge number of presentations and poster sessions, along with a dizzying array of side meetings, networking events, and coffee and drink meetups generated by the presence of 40,000 people focused on cancer.… Read more “PALTOWN goes to ASCO 2017, or how cancerland has finally seen the light.”